84 related articles for article (PubMed ID: 52898)
1. Proceedings: The contribution of individual protease inhibitors to plasma antiplasmin activity.
Crawford GP; Ogston D; Douglas AS
Thromb Diath Haemorrh; 1975 Sep; 34(1):319. PubMed ID: 52898
[No Abstract] [Full Text] [Related]
2. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
3. The measurement of human plasma antiplasmin activity by radial diffusion assay.
Andes WA
Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
[TBL] [Abstract][Full Text] [Related]
4. Immunologic studies on platelet antiproteases.
Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
[No Abstract] [Full Text] [Related]
5. The contribution of plasma protease inhibitors to antiplasmin activity in man.
Crawford GP; Ogston D; Douglas AS
Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
[TBL] [Abstract][Full Text] [Related]
6. [Protease and protease inhibitor activity of blood serum].
Rudenko VG; Levitskiĭ AP
Vrach Delo; 1986 Jun; (6):33-6. PubMed ID: 2428169
[No Abstract] [Full Text] [Related]
7. Proceedings: The change of fibrin split products and plasmin-inhibitor in the newborn infant.
Suzuki S
Thromb Diath Haemorrh; 1975 Sep; 34(1):355. PubMed ID: 52903
[No Abstract] [Full Text] [Related]
8. Alpha 2 macroglobulin and the protease-inhibitory activity of colloid pancreatic preservation solutions.
Donnelly PK; Edwards C; Condie R
Transplant Proc; 1990 Apr; 22(2):535-6. PubMed ID: 1691543
[No Abstract] [Full Text] [Related]
9. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
10. [Activity of selected proteinase inhibitors in patients with disorders of lipid metabolism].
Kopieczna-Grzebieniak E; Drózdz M; Grabowska-Bochenek R; Piekarski M
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):12-4. PubMed ID: 1384011
[TBL] [Abstract][Full Text] [Related]
11. [Protease inhibitors, alpha-1-antitrypsin and alpha-2-macroglobulin, in liver processes].
Tres A; Muñóz JR
Rev Clin Esp; 1977 Jun; 145(6):407-9. PubMed ID: 70046
[No Abstract] [Full Text] [Related]
12. Concentration of some proteinase inhibitors: alpha 1-antitrypsin and alpha 2-macroglobulin in rabbit blood serum in two models of experimental atherosclerosis.
Grabowska-Bochenek R; Drózdz M; Kopieczna-Grzebieniak E; Piekarski M
Acta Biochim Pol; 1990; 37(1):125-7. PubMed ID: 1708185
[TBL] [Abstract][Full Text] [Related]
13. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
Abe T; Kazama M
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
[No Abstract] [Full Text] [Related]
14. [Main proteolytic inhibitors in ocular herpes].
Chesnokova NB; Kasavina BS; Maĭchuk IuF; Kazachenko MA; Shchipanova AI
Vopr Med Khim; 1981; 27(5):663-5. PubMed ID: 6171934
[TBL] [Abstract][Full Text] [Related]
15. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
Oguri T; Hosoi A
Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
[No Abstract] [Full Text] [Related]
16. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
[No Abstract] [Full Text] [Related]
17. [Diagnostic value of determining endogenous proteinase inhibitors in cancer patients].
Shcherbak IG; Potashov LV; Levin AO; Kulikova AI; Sitkevich RV
Vopr Onkol; 1987; 33(3):22-6. PubMed ID: 2436380
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
Gosteva LA
Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
[TBL] [Abstract][Full Text] [Related]
19. Changes in plasminogen levels, plasmin activity and activity of antiplasmins during endotoxin shock in dogs.
Aasen AO; Ohlsson K; Larsbraaten M; Amundsen E
Eur Surg Res; 1978; 10(1):63-72. PubMed ID: 75792
[TBL] [Abstract][Full Text] [Related]
20. Ten-year changes of protease inhibitors in the sons of patients with COPD.
Yoshioka A; Nagata H; Yamamoto M; Akiyama Y; Nishimura M; Miyamoto K; Kishi F; Kawakami Y
Ann N Y Acad Sci; 1991; 624():359-61. PubMed ID: 1712158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
